FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Look at Underlying Trends in Generic Drug Prices: Gottlieb

[ Price : $8.95]

Former FDA deputy commissioner Scott Gottlieb calls on Congress to focus on underlying policies and trends that could lead to an o...

FDA, EMA Advance Mutual Reliance on GMP Inspections

[ Price : $8.95]

FDA meets with European Medicines Agency and GMP experts from EU member states to advance a mutual reliance initiative for GMP ins...

FDA Approves Kubtec Portable X-ray System for Neonates

[ Price : $8.95]

FDA approves a Kubtec PMA for its KUB 250, a portable low-dose digital X-ray system dedicated to the neonatal intensive care unit.

FDA Grants Fast Track for Novavax for RSV F-Protein Vaccine

[ Price : $8.95]

FDA grants Novavax fast track status for its RSV F-Protein nanoparticle vaccine candidate.

Groups Back FDA Drug Compounding Enforcement

[ Price : $8.95]

Six stakeholder groups praise FDAs risk-based approach to regulating drug compounding.

FDA Collection of Info on Risk/Benefit Perception to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection of information on risk and benefit perception scale development to the ...

FDA Seeks Drug Risk/Benefit Perception Measures

[ Price : $8.95]

FDA proposes drug advertising research to give it a pool of measurement tools to evaluate consumer perceptions of risk and benefit...

Gilead Buys Priority Review Voucher for $125 Million

[ Price : $8.95]

Knight Therapeutics sells to Gilead Sciences for $125 million its Neglected Tropical Disease Priority Review Voucher that was gran...

FDA Grants Merrimack Pharma Fast Track Status for MM-398

[ Price : $8.95]

FDA grants Merrimack Pharmaceuticals a fast track designation for MM-398 (nanoliposomal irinotecan injection) for treating patient...

Chemistry Question-based Review MAPP

[ Price : $8.95]

CDERs Office of Pharmaceutical Science issues a MAPP on using a question-based review template.